OK BIOTECH ApS: Financial statements 2018
CVR: 20136693
OK BIOTECH ApS (CVR 20136693) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,496,488 and a net result of DKK -4,413,745 compared with DKK 8,403,349 the year before. Equity amounted to DKK 256,906,501. The solvency ratio was 99.9%.
- Gross Profit
- -1,496,488 kr.
- Profit/Loss
- -4,413,745 kr.
- Equity
- 256,906,501 kr.
- Total Assets
- 257,099,197 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -1.5 mio. | -4.4 mio. | 256.9 mio. | - |
| 2017 | - | -1.7 mio. | 8.4 mio. | 261.3 mio. | - |
| 2016 | - | - | 3 mio. | 252.9 mio. | - |
| 2015 | - | 0 | 190.9 mio. | 249.9 mio. | - |
| 2014 | - | 9.6 mio. | 7.8 mio. | 79 mio. | - |
Keep an eye on OK BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
OK BIOTECH ApS has published its annual report for 2017. Gross profit came to DKK -1,747,193, and the net result was DKK 8,403,349.
About OK BIOTECH ApS
OK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ole Kaae Hansen. The company's owners include Ole Kaae Hansen, Camilla Kaae Wedel and Helene Wedel. In 2025, the company reported a gross profit of DKK -859,156 and a net result of DKK -194,439,082 compared with DKK 11,064,189 the year before. Equity amounted to DKK 82,509,407.
